Garwood Medical Devices, LLC announced that it has raised funds in a round of funding on January 3, 2024. The transaction included participation from new investor, Teijin Limited and funds managed by Pegasus Tech Ventures, Inc.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,536 JPY | 0.00% | -0.26% | +14.93% |
02-09 | Teijin Swings to Fiscal Q1-Q3 Profit | MT |
02-08 | Transcript : Teijin Limited, Q3 2024 Earnings Call, Feb 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.93% | 1.91B | |
+22.72% | 7.61B | |
-1.19% | 3.4B | |
+6.47% | 2.31B | |
+10.94% | 2.11B | |
-2.64% | 2.08B | |
+26.58% | 1.73B | |
-2.58% | 1.66B | |
+9.69% | 1.66B | |
+22.72% | 1.56B |
- Stock Market
- Equities
- 3401 Stock
- News Teijin Limited
- Garwood Medical Devices, LLC announced that it has received funding from Teijin Limited, Pegasus Tech Ventures, Inc.